Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

What sort of treatments are available for patients with dementia and other neurodegenerative conditions? Are these treatments safe and effective? While these questions vary in answers, researchers are currently exploring…

Continue Reading Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

Study: Glomerular Diseases Linked to Greater Risk of Cardivascular Disease

According to a story from Newswise, a recent study concluded that adult patients living with glomerular diseases face an increased chance of cardiovascular disease as well. The findings were first…

Continue Reading Study: Glomerular Diseases Linked to Greater Risk of Cardivascular Disease
New Collaboration Will Develop ARO-AAT for A1AD-Related Liver Disease
source: pixabay.com

New Collaboration Will Develop ARO-AAT for A1AD-Related Liver Disease

  In October 2020, Arrowhead Pharmaceuticals ("Arrowhead") announced a new collaboration and licensing agreement with global biopharmaceutical company Takeda Pharmaceutical Company Limited ("Takeda"). Together, the pair will develop and commercialize…

Continue Reading New Collaboration Will Develop ARO-AAT for A1AD-Related Liver Disease
Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity
[Source: pixabay.com]

Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity

Recently, Docbot, Inc. ("Docbot") announced results from a study performed on Ultivision. Altogether, Docbot's mission has been to create artificial intelligence (AI) technologies that can be applied within a healthcare…

Continue Reading Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity
The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment
source: pixabay.com

The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment

According to a story from GlobeNewswire, the medication dupilumab (marketed as Dupixent®) has demonstrated potential efficacy in a phase 3 clinical trial as a treatment for eosinophilic esophagitis, a rare…

Continue Reading The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment